AIM: Talking Points About GBS and J&J Vaccine
This talking points document was developed by iREACH Subject Matter Experts to provide information on the few cases of GBS reported in individuals who received the J & J COVID-19 vaccines.
This talking points document was developed by iREACH Subject Matter Experts to provide information on the few cases of GBS reported in individuals who received the J & J COVID-19 vaccines.
Announcing the 2024 Immunization Champions award winners! Please read through to learn more about the 2024 Champions from various jurisdictions.
Explore AIM’s latest toolkit that features five promising practices that programs can implement to improve immunization rates.
This talking points document, available in Spanish and English, was developed by iREACH Subject Matter Experts Dr. Yabo Beysolow and Lisa Jacques-Carroll to provide detailed information on the first approved oral antiviral pill for COVID-19 disease.
The wave three report of Understanding Diverse Communities and Supporting Equitable and Informed Vaccination Decision-Making been released.
AIM submitted public comment in November to the Advisory Committee on Immunization Practices (ACIP).
This press release details alarm on measles spread and the announcement of the Vaccine Integrity Project.
This infographic provides actionable recommendations for stakeholders to decrease vaccine hesitancy.
Learn how you can support decision-making in individuals and consider if, and when a COVID-19 vaccination might be right with this infographic.
As part of the Vaccine Access Cooperative (VAC) project, this collection of jurisdiction profiles details AIM’s Southwest/Beaches region.